REFERENCES
- Pascual-Sedano B, Iranzo Alejandro, Marti-Fabregas J, Prospective study of new-onset seizures in patients with human immunodeficiency virus infection. Arch Neurol. 1999;56:610–612.
- Levy RM, Bredesen DE. Central nervous diseases in acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr. 1988;1:41–64.
- Romanelli F, Ryan M. Seizures in HIV-seropositive individuals. CNS Drugs. 2002;16:91–98.
- Holtzman DM, Kaku DA, So YT. New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med. 1989;87:173–177.
- Wong MC, Suite NDA, Labor DR. Seizures in human immunodeficiency virus infection. Arch Neurol. 1990;47:640–642.
- Romanelli F, Jennings HR, Nath A, Ryan M, Berger J. Therapeutic dilemma: the use of anticonvulsants in HIV-positive individuals. Neurology. 2000;54:1404–1407.
- Easterbrook P, Meadway J. The changing epidemiology of HIV infection: new challenges for HIV palliative care. J R Soc Med. 2001;94:442–448.
- Westcarth L, Armstong T. Seizures in people with cancer. Clin J Oncol Nurs. 2007;11:33–37.
- Rajneesh KF, Binder DK. Tumor-associated epilepsy. Neurosurg Focus. 2009;27(2):E1–E4.
- Winter ME. Phenytoin. In Winter ME (ed) Basic Clinical Pharmacokinetics. (pp. 321–363) 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
- Stilman N, Masdeu JC. Incidence of seizures with phenytoin toxicity. Neurology. 1985;35:1769–1772.
- Troupin AS, Ojemann LM. Paradoxical intoxication-a complication of anticonvulsant administration. Epilepsia. 1975;16:753–758.
- Hurwitz AA, Berman JW, Lyman WD. The role of the blood brain barrier in HIV infection of the central nervous system. Adv Neuroimmunol. 1994;4:249–256.
- Kemp LO, Narula P, McPherson ML, Zuckerman I. Medication reconciliation in hospice: a pilot study. Am J Hosp Palliat Care. 2009;26:193–199.
- Golf M, Paice JA, Feulner E, O’Leary C, Marcotte S, Mulcahy M. Refractory status epilepticus. J Palliat Med. 2004;7:85–88.
- Jenkins A. A case of phenytoin toxicity in a patient with advanced lung cancer. Palliat Med. 2006;20:479–480.
- Toler SM, Wilkerson MA, Porter WH, Smith AJ, Chandler MHH. Severe phenytoin intoxication as a result of altered protein binding in AIDS. Ann Pharmacother. 1990;24:698–700.
- Lim ML, Min SS, Eron JJ, Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction. J Acquir Immune Defic Syndr. 2004;36:1034–1040.
- UCB, Inc. Keppra (levetiracetam) package insert. Smyrna, GA; 2007.
- Ben-Menachem E. Preliminary efficacy of levetiracetam in monotherapy. Epileptic Disord. 2003;5(Suppl 1):S51–S55.
- Liedtke MD, Lockhart SM, Rathbun RC. Anticonvulsant and antiretroviral interactions. Ann Pharmacother. 2004;38:482–489.